Newsroom

Press Release - All

• 29 Jul 2026
  Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo
• 28 Jul 2026
  Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26
• 23 Jul 2026
  Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
• 14 Jul 2026
  Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma
• 08 Jul 2026
  Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis
• 01 Jul 2026
  Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight
• 25 Jun 2026
  Agilent Completes Acquisition of Biocare Medical
• 03 Jun 2026
  Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation
• 02 Jun 2026
  Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma
• 01 Jun 2026
  Agilent and Sound Analytics Collaborate to Advance LC/MS Workflows for Drug Metabolism Research